PRESS RELEASE

Q3 2024 — Press release

Q3 2024PDF · 7 pages293 KB
Media Contacts Investor Contact
Laurie Bischel, 312.648.8698 Adam Minick, 312.340.8365
news@cmegroup.com investors@cmegroup.com
cmegroup.mediaroom.com CME-G
FOR IMMEDIATE RELEASE
CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income,
Adjusted Net Income and Adjusted Earnings Per Share for Q3 2024
• Record revenue of $1.6 billion
• Record quarterly ADV of 28.3 million contracts - the second consecutive
quarter of volume, open interest growth across every asset class
CHICAGO, October 23, 2024 - CME Group Inc. (NASDAQ: CME) today reported
financial results for the third quarter of 2024.
The company reported revenue of $1.6 billion and operating income of $1.0 billion for
the third quarter of 2024. Net income was $913 million and diluted earnings per common share
were $2.50. On an adjusted basis, net income was $977 million and diluted earnings per
common share were $2.68. Financial results presented on an adjusted basis for the third
quarter of 2024 and 2023 exclude certain items, which are detailed in the reconciliation of non-
GAAP results.1
"Q3 2024 was the best quarter in CME Group history, with records across volume,
revenue, adjusted operating income, adjusted net income and adjusted earnings per share,”
said Terry Duffy, Chairman and Chief Executive Officer, CME Group. “This marks the second
consecutive quarter of volume and open interest increases across every asset class. Our
financial product volumes rose 28%, reflecting a 36% jump in interest rates to a record ADV of
14.9 million contracts. This was driven by a 35% rise in SOFR futures to a record ADV of 4.1
million contracts and 31% growth in Treasuries to a record ADV of 8.4 million contracts. In
addition, our commodities volume was up 20%, options increased 27% and international ADV
was a record 8.4 million contracts."
Third-quarter 2024 ADV was a record 28.3 million contracts, including record non-U.S.
ADV, with EMEA up 30% and Asia up 28% versus the same period last year.
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of
GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.
- more -

-- 1 of 7 --

Page 2
Clearing and transaction fees revenue for third-quarter 2024 totaled $1.3 billion. The
total average rate per contract was $0.666. Market data revenue totaled $178 million for third-
quarter 2024.
As of September 30, 2024, the company had approximately $2.6 billion in cash
(including $250 million deposited with Fixed Income Clearing Corporation, which is included in
other current assets) and $3.4 billion of debt. The company paid dividends during the third
quarter of approximately $419 million. The company has returned approximately $25.6 billion to
shareholders in the form of dividends since the implementation of the variable dividend policy in
early 2012.
CME Group will hold a Q&A conference call to discuss third-quarter 2024 results
at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on
the Investor Relations section of CME Group's website at investor.cmegroup.com under
Events & Presentations. An archived recording will be available for up to two months
after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients
to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering
market participants worldwide to efficiently manage risk and capture opportunities. CME Group
exchanges offer the widest range of global benchmark products across all major asset classes based on
interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company
offers futures and options on futures trading through the CME Globex platform, fixed income trading via
BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's
leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are
trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of
Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are
trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc.
BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The
S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”,
“SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®,
DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark
Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc.
Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by
S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products.
All other trademarks are the property of their respective owners.
- more -

-- 2 of 7 --

Page 3
Statements in this press release that are not historical facts are forward-looking statements. These
statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are
difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in
any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking
statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of
new information, future events or otherwise. Among the factors that might affect our performance are increasing
competition by foreign and domestic entities, including increased competition from new entrants into our markets and
consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability
to complete the development, implementation and maintenance of the enhanced functionality required by our
customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability
to continue introducing competitive new products and services on a timely, cost-effective basis, including through our
electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services;
our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at
substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand
and globally offer our products and services; changes in regulations, including the impact of any changes in laws or
government policies with respect to our products or services or our industry, such as any changes to regulations and
policies that require increased financial and operational resources from us or our customers; the costs associated
with protecting our intellectual property rights and our ability to operate our business without violating the intellectual
property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to
regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the
trading venue and the mix of customers (whether the customer receives member or non-member fees or participates
in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and
liquidity risk management practices to adequately protect us from the credit risks of clearing members and other
counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal
business; the ability of our compliance and risk management programs to effectively monitor and manage our risks,
including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and
misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk
through third parties, including risks related to the performance, reliability and security of technology used by our
third-party providers and third-party providers that our clients rely on; volatility in commodity, equity and fixed income
prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income
instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of
the capital and credit markets and the impact of economic conditions on the trading activity of our current and
potential customers; our ability to accommodate increases in contract volume and order messaging traffic and to
implement enhancements without failure or degradation of the performance of our trading and clearing systems; our
ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the
costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including
those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in
index services and in trade processing/post trade services (OSTTRA), our primary business and distribution partners’
actions and our partnership with Google Cloud; variances in earnings on cash accounts and collateral that our
clearing house holds for its clients; impact of CME Group pricing and incentive changes; impact of aggregation
services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of
intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to
allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or
concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and
options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates,
borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable
resolution of material legal proceedings. For a detailed discussion and additional information concerning these and
other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on
Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission ("SEC") on
February 28, 2024, under the caption "Risk Factors".
# # #
24-83

-- 3 of 7 --

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
September 30, 2024 December 31, 2023
ASSETS
Current Assets:
Cash and cash equivalents $ 2,322.1 $ 2,912.0
Marketable securities 112.3 111.7
Accounts receivable, net of allowance 629.4 535.6
Other current assets (includes $6.5 and $5.2 in restricted cash) 622.0 1,138.4
Performance bonds and guaranty fund contributions 99,457.0 90,192.5
Total current assets 103,142.8 94,890.2
Property, net of accumulated depreciation and amortization 386.2 409.5
Intangible assets—trading products 17,175.3 17,175.3
Intangible assets—other, net 2,892.2 3,050.2
Goodwill 10,514.1 10,495.3
Other assets 3,684.5 3,685.6
Total Assets $ 137,795.1 $ 129,706.1
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable $ 129.9 $ 90.6
Short-term debt 749.7 —
Other current liabilities 485.2 3,133.8
Performance bonds and guaranty fund contributions 99,457.0 90,192.5
Total current liabilities 100,821.8 93,416.9
Long-term debt 2,677.7 3,425.4
Deferred income tax liabilities, net 5,310.0 5,327.7
Other liabilities 769.4 798.2
Total Liabilities 109,578.9 102,968.2
Total CME Group Shareholders’ Equity 28,216.2 26,737.9
Total Liabilities and Equity $ 137,795.1 $ 129,706.1

-- 4 of 7 --

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Revenues
Clearing and transaction fees $ 1,297.1 $ 1,085.5 $ 3,755.9 $ 3,404.0
Market data and information services 178.2 167.6 528.6 496.5
Other 109.1 84.7 320.3 239.1
Total Revenues 1,584.4 1,337.8 4,604.8 4,139.6
Expenses
Compensation and benefits 218.8 205.5 629.5 615.7
Technology 66.6 55.6 190.1 160.2
Professional fees and outside services 31.0 32.2 98.8 108.3
Amortization of purchased intangibles 55.7 57.2 166.4 171.0
Depreciation and amortization 28.2 31.1 87.0 95.3
Licensing and other fee agreements 97.6 79.5 271.4 242.4
Other 62.3 56.5 177.2 174.2
Total Expenses 560.2 517.6 1,620.4 1,567.1
Operating Income 1,024.2 820.2 2,984.4 2,572.5
Non-Operating Income (Expense)
Investment income 1,026.8 1,272.5 3,142.6 4,198.4
Interest and other borrowing costs (40.2) (39.6) (120.2) (119.7)
Equity in net earnings of unconsolidated subsidiaries 86.1 76.8 259.7 230.1
Other non-operating income (expense) (920.0) (1,155.6) (2,821.7) (3,733.7)
Total Non-Operating Income (Expense) 152.7 154.1 460.4 575.1
Income before Income Taxes 1,176.9 974.3 3,444.8 3,147.6
Income tax provision 264.1 224.1 793.6 736.0
Net Income $ 912.8 $ 750.2 $ 2,651.2 $ 2,411.6
Net Income Attributable to Common Shareholders of CME
Group $ 901.3 $ 740.8 $ 2,617.8 $ 2,381.3
Earnings per Share Attributable to Common Shareholders
of CME Group:
Basic $ 2.51 $ 2.06 $ 7.29 $ 6.63
Diluted 2.50 2.06 7.27 6.62
Weighted Average Number of Common Shares:
Basic 359,400 359,020 359,329 358,965
Diluted 359,989 359,619 359,899 359,448

-- 5 of 7 --

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
3Q 2023 4Q 2023 1Q 2024 2Q 2024 3Q 2024
Trading Days 63 63 61 63 64
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line 3Q 2023 4Q 2023 1Q 2024 2Q 2024 3Q 2024
Interest rates 10,967 13,348 13,839 12,894 14,881
Equity indexes 6,353 6,922 6,856 6,779 7,407
Foreign exchange 942 1,007 984 1,075 1,089
Energy 2,126 2,158 2,412 2,447 2,571
Agricultural commodities 1,433 1,469 1,596 1,877 1,614
Metals 528 609 675 868 728
Total 22,349 25,513 26,360 25,941 28,289
Venue
CME Globex 20,838 23,503 23,985 24,143 26,199
Open outcry 713 1,126 1,333 825 1,096
Privately negotiated 797 885 1,043 974 994
Total 22,349 25,513 26,360 25,941 28,289
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line 3Q 2023 4Q 2023 1Q 2024 2Q 2024 3Q 2024
Interest rates $ 0.508 $ 0.488 $ 0.486 $ 0.484 $ 0.468
Equity indexes 0.625 0.616 0.641 0.628 0.616
Foreign exchange 0.791 0.806 0.787 0.754 0.744
Energy 1.324 1.338 1.334 1.297 1.246
Agricultural commodities 1.328 1.361 1.356 1.366 1.346
Metals 1.492 1.502 1.556 1.511 1.540
Average RPC $ 0.707 $ 0.682 $ 0.695 $ 0.708 $ 0.666
1. ADV and RPC includes futures and options on futures only.

-- 6 of 7 --

CME Group Inc. and Subsidiaries
Reconciliation of GAAP to non-GAAP Measures
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
September 30,
Nine Months Ended
September 30,
2024 2023 2024 2023
Net Income $ 912.8 $ 750.2 $ 2,651.2 $ 2,411.6
Restructuring and severance(1) 6.7 12.6 10.3 14.9
Amortization of purchased intangibles(2) 69.3 70.7 206.9 211.3
Strategic transaction-related costs (credits) — — 0.8 (2.2)
Real estate-related costs (credits) (1.0) — (2.0) —
Foreign exchange transaction (gains) losses 4.3 (1.9) 2.2 (0.1)
Unrealized and realized (gains) losses on investments — 2.0 (11.7) (71.8)
Unrealized and realized (gains) losses on assets — — 0.8 0.4
Litigation matters or settlements 1.2 2.0 1.2 2.0
Income tax effect related to above (16.3) (17.6) (41.3) (28.6)
Other income tax items — — 1.9 (0.8)
Adjusted Net Income $ 977.0 $ 818.0 $ 2,820.3 $ 2,536.7
Adjusted Net Income Attributable to Common Shareholders of
CME Group $ 964.7 $ 807.8 $ 2,784.8 $ 2,504.8
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic $ 2.51 $ 2.06 $ 7.29 $ 6.63
Diluted 2.50 2.06 7.27 6.62
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:
Basic $ 2.68 $ 2.25 $ 7.75 $ 6.98
Diluted 2.68 2.25 7.74 6.97
Weighted Average Number of Common Shares:
Basic 359,400 359,020 359,329 358,965
Diluted 359,989 359,619 359,899 359,448
Preferred shares(3) 4,584 4,584 4,584 4,584
1. Includes $5.3 million of compensation expense due to a law change for vacation carryover in 2024.
2. Includes $11.1 million and $33.2 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.5
million and $7.5 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC in the third quarter
and first nine months of 2024. This is reported in Equity in net earnings of unconsolidated subsidiaries on the
Consolidated Statements of Income.
3. Preferred shares have similar rights as common shares without voting rights.

-- 7 of 7 --